# A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

> clinical trial · VERIFIED · 2026-06-29

Status: RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Follicular Lymphoma

- Company: Merck Sharp & Dohme LLC
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07634471

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.